Qiagen and NCI to Develop siRNAs for Cancer Research
Qiagen and the National Cancer Institute will co-develop and validate a set of siRNAs for cancer genes for use by NCI researchers, Qiagen said this week.
The validated siRNA set will be made available to the general research community following the characterization project, Qiagen said.
Financial terms of the deal were not disclosed.
Illumina, Burnham Institute Will Soon Publish BeadChip Study of Embryonic Stem Cells